KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Esperion Therapeutics (ESPR) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Esperion Therapeutics (ESPR) over the last 8 years, with Sep 2025 value amounting to $677,000.

  • Esperion Therapeutics' Other Non Operating Income fell 57.26% to $677,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $732,000, marking a year-over-year increase of 101.53%. This contributed to the annual value of -$54.9 million for FY2024, which is 1137.95% down from last year.
  • According to the latest figures from Q3 2025, Esperion Therapeutics' Other Non Operating Income is $677,000, which was up 1.65% from $666,000 recorded in Q2 2025.
  • In the past 5 years, Esperion Therapeutics' Other Non Operating Income ranged from a high of $3.9 million in Q4 2021 and a low of -$53.2 million during Q2 2024.
  • Over the past 3 years, Esperion Therapeutics' median Other Non Operating Income value was $1.1 million (recorded in 2023), while the average stood at -$3.9 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 16,312.50% in 2021, then crashed by 3,306.93% in 2024.
  • Esperion Therapeutics' Other Non Operating Income (MRQ) stood at $3.9 million in 2021, then crashed by 65.60% to $1.4 million in 2022, then decreased by 20.30% to $1.1 million in 2023, then plummeted by 255.83% to -$1.7 million in 2024, then surged by 140.23% to $677,000 in 2025.
  • Its Other Non Operating Income was $677,000 in Q3 2025, compared to $666,000 in Q2 2025 and $1.1 million in Q1 2025.